IVIg may affect how your immune system reacts following any vaccination, and this can make the vaccine less effective. Because of this, it is best to avoid vaccinations for at least six weeks after having IVIg.
You will need to avoid live vaccines for three weeks before having IVIg, and for three months afterwards. These vaccines are not live, so it is safe for you to have them.
Talk this over with your surgeon or doctor. You may be able to continue, but your doctor might need to make changes to your dose or the timing of your IVIg treatment. Learn about risks and side-effects. In some circumstances your doctor may advise lower limits. Intravenous immunoglobulin IVIg. Print this page.
What is IVIg? Who can take IVIg? Protect your fetus if you are pregnant and at risk for Rh sensitization. Decrease the immune system's ability to attack body tissues in some cases of autoimmune disease. Help people who have an inherited problem making their own antibodies or those who are having treatment for certain types of cancer such as leukemia.
Treatments for some cancers can cause the body to stop producing its own antibodies, making immunoglobulin treatment necessary. Disease prevention You may be given an immunoglobulin if you are exposed to certain infectious diseases, such as hepatitis A , rubella , or measles. Rh sensitization When an Rh-negative woman becomes pregnant with an Rh-positive fetus which can occur when the father's blood is Rh-positive , the pregnant woman's immune system makes antibodies that can destroy the fetus's blood in a future pregnancy.
Immune thrombocytopenic purpura ITP Immunoglobulin is sometimes used to treat immune thrombocytopenic purpura ITP , an immune disorder in which the body attacks the cells responsible for blood clotting platelets , resulting in bleeding.
Immunological methods and applications. In Roitt's Essential Immunology, 11th ed. Malden, MA: Blackwell Publishing. Credits Current as of: September 23, Top of the page Next Section: Related Information. Previous Section: References Top of the page.
Antibodies can cross the placenta and cause a problem for your baby. This is called hemolytic disease of the newborn HDN.
HDN can cause:. In Canada, the product used is called WinRho. Every time you get pregnant, the risk to your baby is more serious. RhIG has been used in Canada since with very few serious effects reported. If you have questions, talk to your doctor or healthcare provider.
The risk goes up with each pregnancy. If you have any questions or concerns, talk to your doctor or healthcare provider. This material is for information purposes only. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes. Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below. This site complies with the HONcode standard for trustworthy health information: verify here.
This content does not have an English version. This content does not have an Arabic version.
0コメント